Oxysure Systems (OXYS) 0.0335 $OXYS
OxySure Therapeutics (OXYS) May Be Undervalued Compared to Others in Biotech Space
ACCESSWIRE - Mon Mar 21, 8:01AM CDT
REDONDO BEACH, CA / ACCESSWIRE / March 21, 2016 / OxySure Therapeutics Inc. (OTCQB: OXYS), developer of oxygen-from-powder technology and related medical solutions, has come a long way over the past year. Management anticipates reaching a $10 million annual run rate and achieving breakeven later this year. With 14 consecutive quarters of revenue growth, the company has a long track record of increasing shareholder value.
SRDX: 23.37 (+0.47), CFMS: 7.22 (+0.11), GKOS: 29.53 (+0.65), BEAT: 16.05 (+0.76), SCLN: 13.51 (+0.02)
Markets: Investors Looking Toward Renewed Momentum - Research on Directview Holdings, OxySure Therapeutics, Canacol Energy and Badger Daylighting
ACCESSWIRE - Mon Mar 14, 7:10AM CDT
NEW YORK, NY / ACCESSWIRE / March 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Directview Holdings Inc. (OTC: DIRV), OxySure Therapeutics Inc. (OTC: OXYS), Canacol Energy Ltd. (OTC: CNNEF) and Badger Daylighting Ltd. (OTC: BADFF). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
OxySure Therapeutics, Inc. To Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016
ACCESSWIRE - Fri Feb 19, 7:01AM CST
FRISCO, TX / ACCESSWIRE / February 19, 2016 / OxySure Therapeutics, Inc. (OTCQB: OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its "oxygen from powder" technology and other innovative emergency medical solutions, today issued a reminder that the company will present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at The Ritz-Carlton in Miami on South Beach on February 22, 2016. Please click here for a list of presenting companies.
OxySure Therapeutics elects Edward C. Diaz as territory sales manager in South Florida
M2 - Fri Jan 29, 6:30AM CST
Medical device company OxySure Therapeutics (Other OTC:OXYS) disclosed on Thursday the addition of Edward C. Diaz as its territory sales manager of South Florida and portions of the Caribbean Region.
3 Stocks Tackling Concussion Issues in Pro Athletes
ACCESSWIRE - Wed Jan 20, 7:45AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 20, 2016 / The 2015 drama Concussion starring Will Smith follows the story of Dr. Bennet Omalu's battle with the National Football League to acknowledge research on the brain damage suffered by professional football players. After examining the brains of many deceased NFL players, Dr. Omalu coined the term chronic traumatic encephalopathy (CTE) to represent the large accumulation of tau protein on the brain causing a wide range of mental problems.
STEM: 0.57 (+0.19), CEMI: 8.60 (-0.05), CUR: 0.32 (+0.02)
OxySure Therapeutics (OXYS) Welcomes Dr. Zachariah P. Zachariah to Strategic Advisory Board
Marketwire Canada - Wed Jan 13, 9:53AM CST
OxySure Therapeutics, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its "oxygen from powder" technology and other innovative medical solutions today announced that Dr. Zachariah P. Zachariah, a former Director of Ivax Corporation (together with its Chairman Dr. Phil Frost) will be joining OxySure's Strategic Advisory Board effective immediately. Ivax, a marketer of a patented asthma inhaler called Easi-Breathe and other branded respiratory drugs, was acquired by Teva Pharmaceutical Industries for $7.4 billion.
TEVA: 51.97 (-0.04)
OxySure Therapeutics (OXYS) To Present At The 34th Annual J.P. Morgan Healthcare Conference
Marketwire Canada - Wed Jan 06, 7:00AM CST
OxySure Therapeutics, Inc. (OTCQB: OXYS) ("OxySure," or the "Company", a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its "oxygen from powder" technology and other innovative medical solutions will be presenting at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco. Mr. Julian Ross, Chairman and CEO will provide a corporate overview at 12:00 noon on Monday, January 11, 2016 at the SeeThruEquity Microcap Investor event at The Fairmont Hotel, 950 Mason Street, San Francisco, CA 94108.
JPM: 62.37 (+0.09)
OxySure (OXYS) Launches OxyTrac(TM) to Save Lives & Help Companies Stay Compliant
ACCESSWIRE - Thu Dec 10, 7:00AM CST
REDONDO BEACH, CA / ACCESSWIRE / December 10, 2015 / Suppose that you're at a sporting event and someone in the crowd suffers a heart attack and goes into cardiac arrest. A nearby fan responds quickly and calls for help, but stadium employees aren't quite sure where the nearest AED is located. Once a device is finally located, emergency responders attempt to utilize it, but the battery has died. The person ends up dying at the event and the sporting event is sued for their lack of an appropriate response.
SMED: 4.39 (-0.02)
OxySure Systems, Inc. (OXYS) Completes Name Change to OxySure Therapeutics, Inc.
Marketwired - Wed Dec 02, 7:01AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company", a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other innovative medical solutions, today announced the completion of its name change to OxySure Therapeutics, Inc.
Medical Technology Company, OxySure Systems, Reports Results for the 3rd Quarter - 14 Consecutive Quarters of Growth - Video News Alert on InvestmentPitch.com
Newsfile Corp - Fri Nov 20, 9:44AM CST
full story)
OxySure (OXYS) 3Q15 Results -- 14 Consecutive Growth Quarters -- Video News Alert on InvestmentPitch.com
Marketwire Canada - Fri Nov 20, 6:30AM CST
Medical device innovator, OxySure Systems (OTCQB: OXYS) announced results for the 3rd quarter 2015, reporting 14 consecutive quarters of growth.
OxySure Systems: Robust Third Quarter Results Highlight Discount
ACCESSWIRE - Wed Nov 18, 7:31AM CST
REDONDO BEACH, CA / ACCESSWIRE / November 18, 2015 / OxySure Systems Inc. (OTCQB: OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from power" technology and other innovative medical solutions, recently announced robust third quarter financial results. While many over-the-counter stocks fail to live up to expectations, the company's strong performance suggests that the opposite may be occurring - below we will take a look at why many people feel that OxySure is currently undervalued.
NVIV: 6.08 (+0.12), CTSO: 4.29 (-0.04), SMED: 4.39 (-0.02)
OxySure (OXYS) Reports Third Quarter 2015 Financial Results With Annual Run Rate Approaching $5 Million
Marketwired - Tue Nov 17, 6:32AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company", a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other medical solutions, today announced financial and operating results for the third quarter ended September 30, 2015.
OxySure (OXYS) To Host Third Quarter 2015 Financial Results Conference Call 4:15 pm ET on November 16, 2015
Marketwired - Thu Nov 12, 7:31AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company", the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other medical solutions, today announced that it will hold a conference call at 4:15 pm ET on Monday, November 16, 2015 to discuss its financial results for the three and nine months ended September 30, 2015.
OxySure (OXYS) Board Approves Name Change to OxySure Therapeutics, Inc.
Marketwired - Mon Nov 09, 7:01AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company", a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other innovative medical solutions, today announced that its Board of Directors approved a change of the Company's name to OxySure Therapeutics, Inc.
OxySure (OXYS) Files Lawsuit -- Seeks Millions in Damages
Marketwired - Tue Nov 03, 7:03AM CST
OxySure Systems, Inc. (OTCQB: OXYS), ("OxySure," or the "Company", a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other innovative medical solutions, announced today that the Company has filed a lawsuit against TEGNA Inc., WFAA T.V. Channel 8, Jobin Panicker, a reporter for WFAA T.V., The Redwine Law Firm PLLC, and Symone Redwine, an attorney at The Redwine Law Firm.
TGNA: 22.57 (+0.31)
A Watch Out on Active Scrips from Diverse Sectors - Research on Innodata, Oxysure Systems, CytoDyn and Roadships Holdings
ACCESSWIRE - Mon Nov 02, 7:30AM CST
NEW YORK, NY / ACCESSWIRE / November 2, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Innodata Inc. (NASDAQ: INOD), Oxysure Systems Inc. (OTC: OXYS), CytoDyn Inc. (OTC: CYDY) and Roadships Holdings Inc. (OTC: RDSH). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.
INOD: 2.39 (+0.04)
OxySure Therapeutics (OXYS) May Be Undervalued Compared to Others in Biotech Space
ACCESSWIRE - Mon Mar 21, 8:01AM CDT
REDONDO BEACH, CA / ACCESSWIRE / March 21, 2016 / OxySure Therapeutics Inc. (OTCQB: OXYS), developer of oxygen-from-powder technology and related medical solutions, has come a long way over the past year. Management anticipates reaching a $10 million annual run rate and achieving breakeven later this year. With 14 consecutive quarters of revenue growth, the company has a long track record of increasing shareholder value.
SRDX: 23.37 (+0.47), CFMS: 7.22 (+0.11), GKOS: 29.53 (+0.65), BEAT: 16.05 (+0.76), SCLN: 13.51 (+0.02)
Markets: Investors Looking Toward Renewed Momentum - Research on Directview Holdings, OxySure Therapeutics, Canacol Energy and Badger Daylighting
ACCESSWIRE - Mon Mar 14, 7:10AM CDT
NEW YORK, NY / ACCESSWIRE / March 14, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Directview Holdings Inc. (OTC: DIRV), OxySure Therapeutics Inc. (OTC: OXYS), Canacol Energy Ltd. (OTC: CNNEF) and Badger Daylighting Ltd. (OTC: BADFF). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
OxySure Therapeutics, Inc. To Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016
ACCESSWIRE - Fri Feb 19, 7:01AM CST
FRISCO, TX / ACCESSWIRE / February 19, 2016 / OxySure Therapeutics, Inc. (OTCQB: OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its "oxygen from powder" technology and other innovative emergency medical solutions, today issued a reminder that the company will present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at The Ritz-Carlton in Miami on South Beach on February 22, 2016. Please click here for a list of presenting companies.
OxySure Therapeutics elects Edward C. Diaz as territory sales manager in South Florida
M2 - Fri Jan 29, 6:30AM CST
Medical device company OxySure Therapeutics (Other OTC:OXYS) disclosed on Thursday the addition of Edward C. Diaz as its territory sales manager of South Florida and portions of the Caribbean Region.
3 Stocks Tackling Concussion Issues in Pro Athletes
ACCESSWIRE - Wed Jan 20, 7:45AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 20, 2016 / The 2015 drama Concussion starring Will Smith follows the story of Dr. Bennet Omalu's battle with the National Football League to acknowledge research on the brain damage suffered by professional football players. After examining the brains of many deceased NFL players, Dr. Omalu coined the term chronic traumatic encephalopathy (CTE) to represent the large accumulation of tau protein on the brain causing a wide range of mental problems.
STEM: 0.57 (+0.19), CEMI: 8.60 (-0.05), CUR: 0.32 (+0.02)
OxySure Therapeutics (OXYS) Welcomes Dr. Zachariah P. Zachariah to Strategic Advisory Board
Marketwire Canada - Wed Jan 13, 9:53AM CST
OxySure Therapeutics, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its "oxygen from powder" technology and other innovative medical solutions today announced that Dr. Zachariah P. Zachariah, a former Director of Ivax Corporation (together with its Chairman Dr. Phil Frost) will be joining OxySure's Strategic Advisory Board effective immediately. Ivax, a marketer of a patented asthma inhaler called Easi-Breathe and other branded respiratory drugs, was acquired by Teva Pharmaceutical Industries for $7.4 billion. TEVA: 51.97 (-0.04)
OxySure Therapeutics (OXYS) To Present At The 34th Annual J.P. Morgan Healthcare Conference
Marketwire Canada - Wed Jan 06, 7:00AM CST
OxySure Therapeutics, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its "oxygen from powder" technology and other innovative medical solutions will be presenting at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco. Mr. Julian Ross, Chairman and CEO will provide a corporate overview at 12:00 noon on Monday, January 11, 2016 at the SeeThruEquity Microcap Investor event at The Fairmont Hotel, 950 Mason Street, San Francisco, CA 94108. JPM: 62.37 (+0.09)
OxySure (OXYS) Launches OxyTrac(TM) to Save Lives & Help Companies Stay Compliant
ACCESSWIRE - Thu Dec 10, 7:00AM CST
REDONDO BEACH, CA / ACCESSWIRE / December 10, 2015 / Suppose that you're at a sporting event and someone in the crowd suffers a heart attack and goes into cardiac arrest. A nearby fan responds quickly and calls for help, but stadium employees aren't quite sure where the nearest AED is located. Once a device is finally located, emergency responders attempt to utilize it, but the battery has died. The person ends up dying at the event and the sporting event is sued for their lack of an appropriate response.
SMED: 4.39 (-0.02)
OxySure Systems, Inc. (OXYS) Completes Name Change to OxySure Therapeutics, Inc.
Marketwired - Wed Dec 02, 7:01AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other innovative medical solutions, today announced the completion of its name change to OxySure Therapeutics, Inc. Medical Technology Company, OxySure Systems, Reports Results for the 3rd Quarter - 14 Consecutive Quarters of Growth - Video News Alert on InvestmentPitch.com
Newsfile Corp - Fri Nov 20, 9:44AM CST
full story)
OxySure (OXYS) 3Q15 Results -- 14 Consecutive Growth Quarters -- Video News Alert on InvestmentPitch.com
Marketwire Canada - Fri Nov 20, 6:30AM CST
Medical device innovator, OxySure Systems (OTCQB: OXYS) announced results for the 3rd quarter 2015, reporting 14 consecutive quarters of growth.
OxySure Systems: Robust Third Quarter Results Highlight Discount
ACCESSWIRE - Wed Nov 18, 7:31AM CST
REDONDO BEACH, CA / ACCESSWIRE / November 18, 2015 / OxySure Systems Inc. (OTCQB: OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from power" technology and other innovative medical solutions, recently announced robust third quarter financial results. While many over-the-counter stocks fail to live up to expectations, the company's strong performance suggests that the opposite may be occurring - below we will take a look at why many people feel that OxySure is currently undervalued.
NVIV: 6.08 (+0.12), CTSO: 4.29 (-0.04), SMED: 4.39 (-0.02)
OxySure (OXYS) Reports Third Quarter 2015 Financial Results With Annual Run Rate Approaching $5 Million
Marketwired - Tue Nov 17, 6:32AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other medical solutions, today announced financial and operating results for the third quarter ended September 30, 2015. OxySure (OXYS) To Host Third Quarter 2015 Financial Results Conference Call 4:15 pm ET on November 16, 2015
Marketwired - Thu Nov 12, 7:31AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other medical solutions, today announced that it will hold a conference call at 4:15 pm ET on Monday, November 16, 2015 to discuss its financial results for the three and nine months ended September 30, 2015. OxySure (OXYS) Board Approves Name Change to OxySure Therapeutics, Inc.
Marketwired - Mon Nov 09, 7:01AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other innovative medical solutions, today announced that its Board of Directors approved a change of the Company's name to OxySure Therapeutics, Inc. OxySure (OXYS) Files Lawsuit -- Seeks Millions in Damages
Marketwired - Tue Nov 03, 7:03AM CST
OxySure Systems, Inc. (OTCQB: OXYS), ("OxySure," or the "Company"
, a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology and other innovative medical solutions, announced today that the Company has filed a lawsuit against TEGNA Inc., WFAA T.V. Channel 8, Jobin Panicker, a reporter for WFAA T.V., The Redwine Law Firm PLLC, and Symone Redwine, an attorney at The Redwine Law Firm. TGNA: 22.57 (+0.31)
A Watch Out on Active Scrips from Diverse Sectors - Research on Innodata, Oxysure Systems, CytoDyn and Roadships Holdings
ACCESSWIRE - Mon Nov 02, 7:30AM CST
NEW YORK, NY / ACCESSWIRE / November 2, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Innodata Inc. (NASDAQ: INOD), Oxysure Systems Inc. (OTC: OXYS), CytoDyn Inc. (OTC: CYDY) and Roadships Holdings Inc. (OTC: RDSH). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.
INOD: 2.39 (+0.04)
